How Are Antibodies Used in Rapid Tests?
Direct answer: Antibodies are the recognition molecules of an immunochromatographic rapid test. A detection antibody, conjugated to a label (colloidal gold, latex or fluorophore), binds the target in solution; a capture antibody, immobilized at the test line, binds the target–label complex and holds it in place to form a visible line. The quality of these antibodies determines the test's sensitivity, specificity and cross-reactivity.
Two roles: capture and detection
| Role | Location | Function |
|---|---|---|
| Detection antibody | Conjugated to a label, free in the conjugate pad | Binds the target and carries the label |
| Capture antibody | Immobilized at the test line | Binds the target–label complex and holds it in place |
In a sandwich assay the two antibodies bind different epitopes of the same target. In a competitive assay, a single antibody (or a target analog) competes for a limited number of binding sites — the format choice depends on the target's size and structure.
Affinity and specificity
- Affinity — how strongly an antibody binds its target; higher affinity allows detection of lower analyte concentrations (better sensitivity).
- Specificity — how selectively it binds the intended target versus related molecules; higher specificity reduces cross-reactivity (fewer false positives).
Monoclonal vs polyclonal antibodies
| Type | Origin | Characteristics |
|---|---|---|
| Monoclonal | A single B-cell clone | One epitope; high specificity; consistent batches |
| Polyclonal | Multiple B-cell clones | Multiple epitopes; higher avidity; more tolerant of target variation |
Why antibody choice matters
The antibody pair is the single largest determinant of test performance:
- A high-affinity, specific pair → high sensitivity and low cross-reactivity.
- A cross-reactive antibody → false positives against related analytes.
- Poor conjugate stability → weak, variable signal.
This is why antibody screening and validation — affinity, specificity and cross-reactivity testing — is a core step in conjugation and assay development.
What affects antibody-based performance
- Antibody affinity and epitope choice
- Conjugation conditions (pH, concentration, particle size)
- Matrix interference (sample components that bind nonspecifically)
- Reagent and conjugate stability
Limitations
- Cross-reactivity can cause false positives against related molecules
- Antibody quality varies between lots if not carefully controlled
- Low-affinity antibodies miss low analyte levels (false negatives)
Frequently Asked Questions
What is the difference between capture and detection antibodies? The detection antibody is labeled and binds the target in solution; the capture antibody is immobilized at the test line and holds the complex in place.
Why do rapid tests use two antibodies? The sandwich format needs two antibodies binding different epitopes to capture the target specifically and generate a signal.
What causes antibody cross-reactivity? The antibody binds a related (non-target) molecule that shares a similar structure, producing a false positive.
Related knowledge
- What is immunochromatography?
- Colloidal gold conjugation
- Why do false positives and negatives occur?
- Antigen vs antibody
References
- Koczula KM, Gallotta A. Lateral flow assays. Essays Biochem. 2016;60(1):111-120.
- Posthuma-Trumpie GA, Korf J, van Amerongen A. Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. Anal Bioanal Chem. 2009;393(2):569-582.
By Progene Bio Regulatory Affairs Team · Medical Device QA · Medical disclaimer · Last reviewed: 2026-09-12